Showing 1 to 2 of 2 results
Researchers at CityU have identified and demonstrated for the first time a therapeutic small molecule, M1, that can restore the visual function in the mammalian central nervous system, offering hope for patients with optic nerve damage such as glaucoma-related vision loss.
New appointees to the Council and Court of CityU have been announced for a term of three years starting from 1 January 2023.